KPV Peptide – User Manual & Dosage Protocol Guide
Product Overview
KPV (Lysine-Proline-Valine) is a small tripeptide derived from α-MSH (alpha-melanocyte-stimulating hormone), studied for its anti-inflammatory, immunomodulatory, and wound-healing properties.
Research Applications:
- Reducing inflammation in tissues
- Supporting immune system modulation
- Enhancing wound healing and tissue repair
- Potential use in dermatological and gastrointestinal research
Disclaimer: KPV peptide is for research and experimental use only. It is not FDA-approved for therapeutic purposes. Consult a qualified healthcare professional before use.
Forms Available
Product FormLyophilized Powder – Freeze-dried KPV for reconstitution
Injection Solution – Subcutaneous (SC) or intramuscular (IM) solution after reconstitution
Topical Solution / Gel – Experimental application for wound healing or dermatology studies
Mechanism of Action
KPV functions by:
- Inhibiting pro-inflammatory cytokines, reducing tissue inflammation
- Supporting immune modulation
- Enhancing cell migration and tissue repair
- Potentially reducing oxidative stress in tissues
Effects are primarily observed in preclinical and experimental research.
Dosage Protocol (Investigational)
Administration
Subcutaneous (SC) Injection – Typical Dose: 250–500 µg | Frequency: 1–3× per day | Notes: May be used near affected tissue or systemically
Intramuscular (IM) Injection – Typical Dose: 250–500 µg | Frequency: 1–2× per day | Notes: Systemic delivery for research purposes
Topical / Gel Application – Typical Dose: 0.1–1 mg/cm² | Frequency: 1–2× per day | Notes: Local tissue repair and wound healing studies
Cycle Protocol (Investigational)
Initial Phase (1–2 weeks) – Dose: Lower end of dose range | Notes: Assess tolerance
Therapeutic Phase (2–6 weeks) – Dose: Full dose range | Notes: Maximal anti-inflammatory and tissue repair effect
Rest Period (1–2 weeks) – Dose: None | Notes: Allows system to reset before next cycle
Experimental cycles may be repeated 2–3 times per year, depending on research objectives.
Reconstitution Instructions (Lyophilized Powder)
Supplies Needed:
- Sterile bacteriostatic water
- Sterile syringe
- Alcohol swabs
Steps:
- Clean vial top with alcohol swab.
- Add desired volume of bacteriostatic water (e.g., 5 mg peptide + 1 mL water → 5 mg/mL solution).
- Swirl gently to dissolve; do not shake.
- Store refrigerated (2–8°C).
Use within 2–4 weeks; discard if cloudy or discolored.
Administration Guidelines
Subcutaneous Injection (SC)
- Select a clean injection site (abdomen, thigh, or upper arm).
- Clean site with alcohol swab.
- Insert needle at 45° angle.
- Inject slowly; apply gentle pressure afterward.
- Rotate injection sites to avoid tissue irritation.
Intramuscular Injection (IM)
- Select clean muscle site (deltoid, glute, thigh).
- Clean site with alcohol swab.
- Insert needle at 90° angle; inject slowly.
- Apply gentle pressure afterward.
Topical / Gel Application
- Apply a thin layer to the affected area 1–2× per day.
- Clean area before application.
- Cover with sterile dressing if required for research purposes.
Storage Guidelines
Storage Information
Lyophilized Powder – Storage: Cool, dry place | Shelf Life: Up to 12 months
Reconstituted Solution – Storage: Refrigerate 2–8°C | Shelf Life: 2–4 weeks
Topical / Gel – Storage: Refrigerate or room temperature | Shelf Life: 1–3 months
Discard solution if cloudy, discolored, or containing particulates.
Safety & Precautions
- Not recommended for pregnant or breastfeeding women
- Avoid if allergic to peptides
- Mild side effects: injection site irritation, redness, or mild itching
- Discontinue if severe adverse reactions occur
- Keep out of reach of children
Human clinical data are limited; effects are investigational.
Quick Reference Cycle Chart (Investigational)
Weekly Dosing Schedule
Week 1–2 – Dose: 250 µg SC/IM 1× per day | Notes: Initial tolerance phase
Week 3–4 – Dose: 250–500 µg SC/IM 1–2× per day | Notes: Therapeutic phase
Week 5–6 – Dose: 500 µg SC/IM 2–3× per day | Notes: Full effect cycle
Week 7+ – Dose: Rest 1–2 weeks | Notes: Reset before next cycle
Visual Guide
- Diagrams of SC and IM injection sites (abdomen, thigh, arm, deltoid, glute)
- Step-by-step reconstitution guide
- Topical application illustration
- Safety icons for handling, storage, and injections